MINDSTATE DESIGN LABS
Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions. The company maps the biological basis of the varieties of psychedelic experiences and uses that map to design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders.
MINDSTATE DESIGN LABS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.mindstate.design
Total Employee:
1+
Status:
Active
Total Funding:
11.63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Antheia
A synthetic biology company for next generation plant-inspired medicines
Celularity
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Morphic Therapeutic
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Naval Ravikant
Naval Ravikant investment in Seed Round - Mindstate Design Labs
Negev Capital
Negev Capital investment in Seed Round - Mindstate Design Labs
Initialized Capital
Initialized Capital investment in Seed Round - Mindstate Design Labs
Rand Hindi
Rand Hindi investment in Seed Round - Mindstate Design Labs
Apoorva Mehta
Apoorva Mehta investment in Seed Round - Mindstate Design Labs
Max Hodak
Max Hodak investment in Seed Round - Mindstate Design Labs
Fred Ehrsam
Fred Ehrsam investment in Seed Round - Mindstate Design Labs
Page One Ventures
Page One Ventures investment in Seed Round - Mindstate Design Labs
K50 Ventures
K50 Ventures investment in Seed Round - Mindstate Design Labs
Innovating Capital
Innovating Capital investment in Seed Round - Mindstate Design Labs
Official Site Inspections
http://www.mindstate.design
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Mindstate Design Labs"
Mindstate Design Labs
We’ve combined natural history, natural language processing, and biochemical data to build a predictive model for the precision design of modified conscious states.See details»
Mindstate Design Labs - Crunchbase Company Profile & Funding
Mindstate Design Labs is a clinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics. View contacts for Mindstate Design Labs to access new …See details»
Mindstate Design Labs - LinkedIn
Preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics. ??? Inspiring words from the legendary Jason Silva. Mindstate is "...taking...See details»
Mindstate Design Labs raised an $11.5M seed round …
Feb 11, 2022 · Pittsburgh-based preclinical biotech startup Mindstate Design Labs announced yesterday that it had raised an $11.5 million seed round to advance its mission of creating psychedelic-inspired therapeutics, including its …See details»
Mindstate Design Labs - Y Combinator
Mar 13, 2024 · Developing the next generation of psychedelic therapeutics for mental health indications. We design novel altered states of consciousness using machine learning, human experiential data, and molecular pharmacology. Are …See details»
Mindstate Uses AI to Design “Next-Gen” Psychedelics Combined …
Sep 20, 2024 · Mindstate Design Labs has received approval for a Phase 1 clinical trial to investigate the use of its formulation of 5-MeO-MiPT which it hopes to combine with other …See details»
Mindstate heads to the clinic with first AI-derived …
Mar 13, 2024 · Mindstate Design Labs has submitted its first IND, asking the FDA to greenlight a clinical trial for its lead asset targeting 5-MeO-MiPT, also known as moxy, a psychedelic selected from more...See details»
Mindstate Design Labs Raised a $11.5 Million Seed …
Feb 10, 2022 · The psychedelics startup Mindstate Design Labs just raised an $11.5 million seed round. Its investor list includes big names from Silicon Valley, including Neuralink cofounder Max Hodak....See details»
Mindstate Design Labs - Funding, Financials, Valuation & Investors
Mindstate Design Labs is a clinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics.See details»
Y Combinator Startup Uses AI To Design New Drug-Induced
Feb 10, 2022 · Mindstate Design Labs is a biotech startup focused on developing new drugs capable of inducing curated states of mind. The company has raised $11.5 million in a seed …See details»
The psychedelic AI found - POLITICO
Mar 18, 2024 · Mindstate Design Labs picked the drug, also known as moxy, using an AI model it built and trained on more than 70,000 “trip reports” of people using psychedelics pulled from …See details»
Mindstate Design Labs | VentureRadar
Website: https://www.mindstate.design/ Develops advanced psychedelic therapies for mental health conditions using biological insights for precision design of therapeutic mental states, …See details»
Mindstate Design Labs - VentureRadar
Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.See details»
Mindstate Design Labs - PitchBook
May 14, 2021 · Developer of psychedelic-inspired therapeutics designed for intractable mental and behavioral health conditions. The company's platform uses natural history and …See details»
Safer Psychedelic Drugs May Be Coming | TIME
Oct 2, 2024 · To that end, Mindstate Design Labs is working to build drugs that cause psychedelic trips, but selectively. “Psychedelics are very promiscuous molecules,” Mindstate CEO DiNardo …See details»
Designing States of Consciousness - Third Wave
Dillan DiNardo is the CEO of Mindstate Design Labs, a next-generation psychedelic biotech company designing novel altered states of consciousness for mental health therapeutics.See details»
Dillan DiNardo - CEO of Mindstate Design Labs - YouTube
Feb 10, 2022 · Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therape...See details»
A NEW KIND OF MIND WITH MINDSTATE DESIGN LABS - YouTube
Oct 3, 2024 · Mindstate Design Labs is a new biotech startup design a new generation of designer psychedelics - 21st century “better living through chemistry” to address t...See details»
Founder & CEO @ Mindstate Design Labs - Crunchbase
Dillan DiNardo is a Founder & CEO at Mindstate Design Labs, a next-generation psychedelic drug development company. Prior to Mindstate Design Labs he worked in a $1 billion venture fund, …See details»
Mindstate Design Labs - VentureRadar
Website: https://www.mindstate.design/ Develops advanced psychedelic therapies for mental health conditions using biological insights for precision design of therapeutic mental states, …See details»